As of May 7, 2026, CDC data shows 1,842 confirmed measles cases across 39 U.S. jurisdictions this year, with 25 new outbreaks driving 93% of infections, primarily among unvaccinated individuals (92% of cases). Declining kindergarten MMR vaccination coverage at 92.5%—below the 95% herd immunity threshold—has enabled sustained local transmission from imported cases amid global measles resurgence. Hospitalization rates are 6%, with no fatalities reported. Year-to-date totals already approach 2025's 2,144 cases, fueled by close-contact settings and travel; traders should monitor weekly CDC surveillance updates, summer travel peaks, and back-to-school vaccination drives for potential surges or containment.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоСлучаи кори в США в 2026 году?
Случаи кори в США в 2026 году?
$7,666,686 Объем
$7,666,686 Объем
31 дек. 2026 г.
↑2к
99%
↑3к
61%
↑4k
27%
↑5к
16%
↑7,5 тыс.
15%
↑10k
8%
↑12,5 тыс.
5%
$7,666,686 Объем
$7,666,686 Объем
31 дек. 2026 г.
↑2к
$45,338 Объем
99%
↑3к
$50,190 Объем
61%
↑4k
$170,347 Объем
27%
↑5к
$215,323 Объем
16%
↑7,5 тыс.
$173,458 Объем
15%
↑10k
$6,492,455 Объем
8%
↑12,5 тыс.
$344,823 Объем
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of May 7, 2026, CDC data shows 1,842 confirmed measles cases across 39 U.S. jurisdictions this year, with 25 new outbreaks driving 93% of infections, primarily among unvaccinated individuals (92% of cases). Declining kindergarten MMR vaccination coverage at 92.5%—below the 95% herd immunity threshold—has enabled sustained local transmission from imported cases amid global measles resurgence. Hospitalization rates are 6%, with no fatalities reported. Year-to-date totals already approach 2025's 2,144 cases, fueled by close-contact settings and travel; traders should monitor weekly CDC surveillance updates, summer travel peaks, and back-to-school vaccination drives for potential surges or containment.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Открытие рынка: Dec 1, 2025, 12:56 PM ET
Объем
$7,666,686Дата окончания
31 дек. 2026 г.Открытие рынка
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of May 7, 2026, CDC data shows 1,842 confirmed measles cases across 39 U.S. jurisdictions this year, with 25 new outbreaks driving 93% of infections, primarily among unvaccinated individuals (92% of cases). Declining kindergarten MMR vaccination coverage at 92.5%—below the 95% herd immunity threshold—has enabled sustained local transmission from imported cases amid global measles resurgence. Hospitalization rates are 6%, with no fatalities reported. Year-to-date totals already approach 2025's 2,144 cases, fueled by close-contact settings and travel; traders should monitor weekly CDC surveillance updates, summer travel peaks, and back-to-school vaccination drives for potential surges or containment.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Объем
$7,666,686Дата окончания
31 дек. 2026 г.Открытие рынка
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...As of May 7, 2026, CDC data shows 1,842 confirmed measles cases across 39 U.S. jurisdictions this year, with 25 new outbreaks driving 93% of infections, primarily among unvaccinated individuals (92% of cases). Declining kindergarten MMR vaccination coverage at 92.5%—below the 95% herd immunity threshold—has enabled sustained local transmission from imported cases amid global measles resurgence. Hospitalization rates are 6%, with no fatalities reported. Year-to-date totals already approach 2025's 2,144 cases, fueled by close-contact settings and travel; traders should monitor weekly CDC surveillance updates, summer travel peaks, and back-to-school vaccination drives for potential surges or containment.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы